NewAmsterdam Pharma Company N.V. (NAMS) Net income 2021–2025
NewAmsterdam Pharma Company N.V. (NAMS) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$203.0MFY2025 · since FY2021: -$41.8M → -$203.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$203.0M | +16.1% |
| FY2024 | -$242.0M | -36.7% |
| FY2023 | -$177.0M | -682.0% |
| FY2022 | -$22.6M | +45.8% |
| FY2021 | -$41.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice